Skip to cookie consent Skip to main content

Portfolio Companies

We support companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science. Since inception in 2008, we have invested in 55 companies, realized 16 successful exits, and produced top venture returns.

Active portfolio companies

Exited portfolio companies

Since inception, Mass General Brigham Ventures has realized 16 exits, including seven initial public offerings and nine trade sales. These portfolio companies are spearheading novel approaches to diagnose, prevent and treat a wide range of medical conditions.